Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01855425 · ClinicalTrials.gov registry record · NA
Cone Beam CT for Diagnosis of Select Otorhinolaryngology (ENT) Indications at Lower Dose
A NA study, sponsored by Carestream Health.
- Completed
- Registry status
- NA
- Development phase
- 96
- Enrollment target
NCT01855425: Completed NA study, sponsored by Carestream Health.
NCT01855425 is a NA study that has completed, run by Carestream Health. The registered enrollment target is 96 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (93% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01855425, a NA study, has completed, sponsored by Carestream Health.
- COMPLETED
- Registry status
- NA
- Development phase
- 96 participants
- Enrollment target
Study Summary
The study objective is to compare the CBCT images generated by the CS 9300 to those generated by conventional CT.
Primary Outcome
Percentage of Participants with \>=3 Diagnostic Rating Using Radlex Scale. Five radiologists participated in reader study using Radlex scale below to analyze and rate participant images. They determined if they could make a medical diagnosis for ENT patients. Used Radlex Scale - 1-Non-diagnostic, Unacceptable for diagnostic purposes. 2-Limited Acceptable, with some technical defect. 3-Diagnostic, Image quality that would be expected routinely when imaging cooperative patients. 4-Exemplary, Good
Interventions
- RADIATION Radiation
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 96 participants |
| Start Date | 2012-09-21 |
| Est. Completion | 2013-08-09 |
| Phase | NA |
What the finished NCT01855425 record still lists
NCT01855425 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 96 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (93% lower).
The record links to 0 conditions, and to 1 intervention - of which Radiation is the first listed.
NCT01855425 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01855425 about?
NCT01855425 is a clinical study titled "Cone Beam CT for Diagnosis of Select Otorhinolaryngology (ENT) Indications at Lower Dose". The study objective is to compare the CBCT images generated by the CS 9300 to those generated by conventional CT.
What is the current status of trial NCT01855425?
This trial is currently completed. It is a NA study. The enrollment target is 96 participants. The study started on 2012-09-21. Estimated completion is 2013-08-09.
What interventions are being tested in trial NCT01855425?
The interventions under investigation include: Radiation (RADIATION).
Who is sponsoring clinical trial NCT01855425?
This trial is sponsored by Carestream Health, which has 4 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01855425's enrollment target sits among peer trials
96 925th of 2000 higher than 1,070 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03401762 · 96 participants · NA
Wearable MCI to Reduce Muscle Co-activation in Acute and Chronic Stroke
- NCT03471260 · 96 participants · Phase 1
Ivosidenib and Venetoclax With or Without Azacitidine in Treating Patients With IDH1 Mutated Hematologic Malignancies
- NCT03549559 · 96 participants · NA
Imaging Histone Deacetylase in the Heart
- NCT03841058 · 96 participants · Phase 2
Abaloparatide vs. Placebo in Post-Menopausal Women and Abaloparatide in Men Receiving Initial Spinal Fusion Surgery
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI